Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
M. Moor, F. Suter-Riniker, M. Horn, D. Aeberli +16 more

